We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App

New One-Piece Injection-Molded COVID-19 Swab to Enable Expanded Testing

By LabMedica International staff writers
Posted on 29 Jun 2020
Print article
Image: The Hoowaki NP Collection Swab (Photo courtesy of Hoowaki LLC)
Image: The Hoowaki NP Collection Swab (Photo courtesy of Hoowaki LLC)
An innovative one-piece injection molded design for a COVID-19 swab could help close the gap in US and global COVID-19 testing supplies.

The Hoowaki NP Collection Swab has been developed by Hoowaki LLC (Greenville, SC, USA) using its proprietary HOOWAKI MICROGRIP surface technology to create micro-pillars. The swab met existing industry-standard products for flexibility and performance in clinical user testing and has also proven to be equivalent to the industry-standard flocked filament swabs in the collection of patient RNA that is critical for COVID-19 testing in independent laboratory testing (qPCR Assay). Mass-production of the FDA registered, patent pending, Hoowaki NP Collection Swab will begin this summer and is expected to reach at least several million units per month.

The proprietary Hoowaki NP Collection Swab is manufactured using advanced injection molding technologies that utilize existing equipment that is readily available in communities throughout the world. The swab's scalability is due to Hoowaki LLC's formulations and engineering designs working at existing injection molding facilities, which enables the swab to be produced in quantities that meet local demands anywhere in the world.

"The Hoowaki NP Collection Swab is an important answer to the challenges posed by the global COVID-19 pandemic," said Ralph Hulseman, president of Hoowaki LLC. "Our design allows for production to be quickly scaled in communities around the world—rapidly addressing the rising demand for swabs, a critically important element of all COVID-19 testing."

Related Links:
Hoowaki LLC

Print article


Molecular Diagnostics

view channel
Image: The Chemagic 360 extracts DNA and uses transiently magnetized rods to attract the beads after binding to the nucleic acids (Photo courtesy of PerkinElmer).

Blood Group Locus Contributes to COVID-19 Severity Risk

There is considerable variation in disease behavior among patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19).... Read more
Copyright © 2000-2020 Globetech Media. All rights reserved.